Trials / Active Not Recruiting
Active Not RecruitingNCT03585621
Stereotactic Body Radiation Therapy for Breast Cancer
A Phase I-II Study of Stereotactic Body Radiation Therapy for Breast Cancer (SBRT Breast)
- Status
- Active Not Recruiting
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 24 (estimated)
- Sponsor
- Toronto Sunnybrook Regional Cancer Centre · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
This is a prospective, single institution, phase I-II study of stereotactic body radiotherapy (SBRT) for unresected breast cancer. Twenty-four patients with advanced breast cancer who are not candidates for surgery (metastatic disease, unresectable, medically inoperable) or decline surgery will be enrolled in a prospective study using SBRT (4 fractions of radiation therapy over 12-15 days) as the primary treatment modality.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| RADIATION | SBRT | Each radiation treatment plan will be customized to the patient and tumour in order to deliver highly conformal, conebeam CT guided SBRT radiotherapy in 4 fractions delivered over 2-4 weeks. |
Timeline
- Start date
- 2018-07-17
- Primary completion
- 2024-09-01
- Completion
- 2026-07-17
- First posted
- 2018-07-13
- Last updated
- 2025-09-09
Locations
1 site across 1 country: Canada
Source: ClinicalTrials.gov record NCT03585621. Inclusion in this directory is not an endorsement.